2-aminopurine has been researched along with cyc 202 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conrad, D; Dai, Y; Dent, P; Grant, S; Krystal, G; Rahmani, M; Yu, C | 1 |
| Chu, B; Mohapatra, S; Pledger, WJ; Zhao, X | 1 |
| Indorato, RL; Lacroix, F; Margolis, RL; Panopoulos, A; Skoufias, DA | 1 |
3 other study(ies) available for 2-aminopurine and cyc 202
| Article | Year |
|---|---|
The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Topics: 2-Aminopurine; Antineoplastic Agents; Apoptosis; Chromones; Cyclin-Dependent Kinases; Drug Synergism; Enzyme Inhibitors; Flavonoids; Humans; Leukemia; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Purines; Roscovitine; Tumor Cells, Cultured | 2003 |
Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells.
Topics: 2-Aminopurine; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Cyclin-Dependent Kinases; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Protein Kinase Inhibitors; Proteins; Purines; Roscovitine; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein | 2005 |
Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed.
Topics: 2-Aminopurine; CDC2 Protein Kinase; Coloring Agents; Cysteine Proteinase Inhibitors; Drug Interactions; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; HCT116 Cells; HeLa Cells; Humans; Hydrolysis; Lactams; Leupeptins; Mitosis; Phosphoprotein Phosphatases; Propidium; Protein Kinase Inhibitors; Purines; Roscovitine | 2007 |